Partial
Mostly Aligned
Patient Risk:
Low
Summary
Partial alignment with the label. Three statements found to be supported by the label (B12 absorption decreases with long-term metformin; neuropathy and anemia can accompany B12 deficiency). The majority of extracted claims are not supported or are unsupported/inaccurate per the provided label.
Category Scores
Accurate Statements
Metformin reduces B12 absorption in the gut.
METFORMIN LABEL: WARNINGS AND PRECAUTIONS — Vitamin B12 deficiency and decreased absorption associated with long-term metformin use.
Deficiency symptoms include neuropathy.
METFORMIN LABEL: WARNINGS AND PRECAUTIONS — Neurologic symptoms due to vitamin B12 deficiency (e.g., neuropathy).
Deficiency symptoms include anemia.
METFORMIN LABEL: WARNINGS AND PRECAUTIONS — Vitamin B12 deficiency can cause anemia (megaloblastic/macromytic anemia).
Unsupported Statements
B12 vitamins can be taken with metformin.
Not present in label.
Metformin use leads to B12 deficiency in up to 30% of long-term users.
Not present in label.
B12 supplementation prevents B12 deficiency caused by metformin.
Not present in label.
B12 supplementation does not interfere with metformin's blood sugar control.
Not present in label.
Metformin alters calcium-dependent processes in the ileum, impairing intrinsic factor-mediated B12 uptake.
Not present in label.
B12 levels drop after 4-12 weeks of metformin use.
Not present in label.
Risks of B12 deficiency rise after a year of metformin use.
Not present in label.
Deficiency symptoms include fatigue.
Not present in label.
Deficiency symptoms include cognitive issues.
Not present in label.
B12 dosing is 500-1,000 mcg daily of oral cyanocobalamin or methylcobalamin.
Not present in label.
Higher sublingual B12 doses may be used if deficient.
Not present in label.
B12 injections may be used if deficient.
Not present in label.
B12 can be taken any time.
Not present in label.
If concerned about minor interactions, separate B12 dose by 2 hours from metformin.
Not present in label.
Evidence for a significant interaction between B12 and metformin is weak.
Not present in label.
B12 levels should be checked annually via blood tests (serum B12 and methylmalonic acid).
Not present in label.
Start B12 supplements proactively if on metformin for more than 6 months.
Not present in label.
ADA and endocrine societies advise screening high-risk patients and supplementing as needed.
Not present in label.
There is no blanket contraindication to B12 supplementation with metformin.
Not present in label.
Fatigue is a sign you might need B12 testing.
Not present in label.
Tingling in hands or feet is a sign you might need B12 testing.
Not present in label.
Pale skin is a sign you might need B12 testing.
Not present in label.
Memory fog is a sign you might need B12 testing.
Not present in label.
Unexplained anemia is a sign you might need B12 testing.
Not present in label.
Vegans have a higher risk of B12 deficiency with metformin.
Not present in label.
People with GI issues have a higher risk of B12 deficiency with metformin.
Not present in label.
Switching to extended-release metformin results in less B12 impact.
Not present in label.
Folate checks may be added.
Not present in label.
Vitamin D checks may be added.
Not present in label.
In severe cases, doctors may prescribe B12 injections.
Not present in label.
Contradictions
Important Omissions
Dosing guidelines or prophylaxis for B12 with metformin are not provided in the label claims evaluated.
Importance:
High
Monitoring recommendations for B12 status (e.g., MMA, serum B12) are not described in the label sections provided.
Importance:
High
No explicit guidance on routine B12 screening intervals or AS/ADA-related recommendations in label context.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Label-supported information centers on B12 deficiency risk with long-term metformin; no additional high-risk safety signals identified in the evaluated claims.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
On-label content limited to B12 deficiency warning; many dosing/prophylaxis and monitoring claims go beyond label.
Suggested Improvement
Restrict statements to on-label warnings and mechanisms of deficiency; avoid dosing or prophylaxis recommendations not described in the label; cite exact label sections for any on-label claims.